USANA HEALTH SCIENCES INC (USNA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 01-03. Amounts in USD.

Revenue TTM

0 500M 1B 1.5B Q4 '18: 1B Q1 '19: 1.1B Q2 '19: 1.1B Q3 '19: 1.2B Q4 '19: 1.2B Q1 '20: 1.2B Q2 '20: 1.1B Q3 '20: 1.1B Q4 '20: 1.1B Q1 '21: 1.1B Q2 '21: 1.1B Q3 '21: 1.1B Q4 '21: 1.1B Q1 '22: 1.2B Q2 '22: 1.3B Q3 '22: 1.2B Q4 '22: 1.2B Q1 '23: 1.2B Q2 '23: 1.1B Q3 '23: 1B Q4 '23: 998.6M Q1 '24: 974.1M Q2 '24: 947.8M Q3 '24: 927.9M Q4 '24: 921M Q1 '25: 900.5M Q2 '25: 875.1M Q3 '25: 862M Q4 '25: 854.5M Q1 '26: 876.2M Q2 '26: 899.2M Q3 '26: 912.7M Q4 '26: 925.3M Q1 '27: 925.9M Q2 '27: 913.4M Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26 Q2 '27

Gross Profit TTM

0 350M 700M 1.1B Q4 '11: 422.2M Q1 '12: 444M Q2 '12: 463.4M Q3 '12: 471.9M Q4 '12: 480.2M Q1 '13: 489.2M Q2 '13: 499.4M Q3 '13: 515.9M Q4 '13: 532.9M Q1 '14: 544.8M Q2 '14: 569.2M Q3 '14: 576.6M Q4 '14: 590.7M Q1 '15: 600.5M Q2 '15: 596.7M Q3 '15: 611.8M Q4 '15: 649.7M Q1 '16: 682.1M Q2 '16: 721.9M Q3 '16: 756.8M Q4 '16: 758.8M Q1 '17: 775.3M Q2 '17: 794.7M Q3 '17: 811.7M Q4 '17: 825.9M Q1 '18: 841M Q2 '18: 841.6M Q3 '18: 847M Q4 '18: 867.9M Q1 '19: 897.8M Q2 '19: 936.1M Q3 '19: 966.4M Q4 '19: 988.5M Q1 '20: 973M Q2 '20: 931.1M Q3 '20: 898.9M Q4 '20: 873.4M Q1 '21: 866.9M Q2 '21: 868.7M Q3 '21: 898M Q4 '21: 925.5M Q1 '22: 955.3M Q2 '22: 1B Q3 '22: 1B Q4 '22: 968.6M Q1 '23: 939.7M Q2 '23: 874.9M Q3 '23: 838M Q4 '23: 804.7M Q1 '24: 783.1M Q2 '24: 763M Q3 '24: 747.1M Q4 '24: 744.3M Q1 '25: 729.2M Q2 '25: 706.9M Q3 '25: 697M Q4 '25: 693.3M Q1 '26: 705.7M Q2 '26: 718.8M Q3 '26: 722.7M Q4 '26: 724.4M Q1 '27: 718.1M Q2 '27: 707.4M Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25 Q2 '27

Operating Income TTM

-70M 0 70M 140M 210M Q4 '11: 68.2M Q1 '12: 71M Q2 '12: 75M Q3 '12: 75.3M Q4 '12: 77.3M Q1 '13: 80.9M Q2 '13: 84.9M Q3 '13: 90.2M Q4 '13: 98.2M Q1 '14: 103.9M Q2 '14: 115.2M Q3 '14: 115.8M Q4 '14: 116.7M Q1 '15: 115.3M Q2 '15: 107.9M Q3 '15: 112.5M Q4 '15: 116.1M Q1 '16: 120.8M Q2 '16: 130.5M Q3 '16: 139.2M Q4 '16: 141.7M Q1 '17: 145.4M Q2 '17: 144.1M Q3 '17: 141.9M Q4 '17: 138.6M Q1 '18: 138M Q2 '18: 132.9M Q3 '18: 128.4M Q4 '18: 132.5M Q1 '19: 142.7M Q2 '19: 161.5M Q3 '19: 175.7M Q4 '19: 188.4M Q1 '20: 180.2M Q2 '20: 160.2M Q3 '20: 150.2M Q4 '20: 146.2M Q1 '21: 150.2M Q2 '21: 158.6M Q3 '21: 168.5M Q4 '21: 176.5M Q1 '22: 181.7M Q2 '22: 195.8M Q3 '22: 191.2M Q4 '22: 170.2M Q1 '23: 159.1M Q2 '23: 134.7M Q3 '23: 116.6M Q4 '23: 107.6M Q1 '24: 101.4M Q2 '24: 96.4M Q3 '24: 91.4M Q4 '24: 93.1M Q1 '25: 90.9M Q2 '25: 84.3M Q3 '25: 82.3M Q4 '25: 66.3M Q1 '26: 57.3M Q2 '26: 56.2M Q3 '26: 41.8M Q4 '26: 37.4M Q1 '27: 35.6M Q2 '27: -1.1M Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25 Q2 '27

Net Income TTM

-50M 0 50M 100M 150M Q4 '11: 45.7M Q1 '12: 47.4M Q2 '12: 50.4M Q3 '12: 50M Q4 '12: 50.8M Q1 '13: 53.2M Q2 '13: 56M Q3 '13: 61.1M Q4 '13: 66.4M Q1 '14: 70.5M Q2 '14: 77.9M Q3 '14: 77.2M Q4 '14: 79M Q1 '15: 77.8M Q2 '15: 72.9M Q3 '15: 75.6M Q4 '15: 76.6M Q1 '16: 79.8M Q2 '16: 85.9M Q3 '16: 92M Q4 '16: 94.7M Q1 '17: 97.3M Q2 '17: 97.6M Q3 '17: 102.1M Q4 '17: 100M Q1 '18: 99.1M Q2 '18: 96.6M Q3 '18: 90.3M Q4 '18: 62.5M Q1 '19: 70.1M Q2 '19: 80.8M Q3 '19: 88M Q4 '19: 126.2M Q1 '20: 121.5M Q2 '20: 108.9M Q3 '20: 102.1M Q4 '20: 100.5M Q1 '21: 102.9M Q2 '21: 109.5M Q3 '21: 115.8M Q4 '21: 124.7M Q1 '22: 128.7M Q2 '22: 139M Q1 '23: 108.4M Q2 '23: 89.3M Q3 '23: 76.9M Q4 '23: 69.3M Q1 '24: 65.3M Q2 '24: 63.4M Q3 '24: 59.8M Q4 '24: 63.8M Q1 '25: 61.9M Q2 '25: 55.1M Q3 '25: 54.3M Q4 '25: 42M Q1 '26: 34.9M Q2 '26: 34.1M Q3 '26: 17M Q4 '26: 10.8M Q1 '27: 8.9M Q2 '27: -22.2M Q4 '12 Q4 '14 Q4 '16 Q4 '18 Q4 '20 Q2 '23 Q2 '25 Q2 '27

Cost of Revenue TTM

0 80M 160M 240M Q2 '19: 192.2M Q3 '19: 197M Q4 '19: 200.7M Q1 '20: 197.2M Q2 '20: 193.7M Q3 '20: 189.7M Q4 '20: 187.5M Q1 '21: 187.7M Q2 '21: 188.8M Q3 '21: 197.4M Q4 '21: 209.1M Q1 '22: 220.7M Q2 '22: 230M Q3 '22: 224.4M Q4 '22: 217.9M Q1 '23: 211.6M Q2 '23: 204.1M Q3 '23: 200M Q4 '23: 193.9M Q1 '24: 191M Q2 '24: 184.8M Q3 '24: 180.8M Q4 '24: 176.7M Q1 '25: 171.2M Q2 '25: 168.2M Q3 '25: 165M Q4 '25: 161.2M Q1 '26: 170.6M Q2 '26: 180.4M Q3 '26: 190M Q4 '26: 200.9M Q1 '27: 207.8M Q2 '27: 206M Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26 Q2 '27

Operating Cash Flow TTM

0 60M 120M 180M Q2 '12: 72.2M Q3 '12: 73.3M Q4 '12: 70.1M Q1 '13: 75.2M Q2 '13: 82.7M Q3 '13: 80.3M Q4 '13: 92.8M Q1 '14: 90.5M Q2 '14: 96.2M Q3 '14: 93.8M Q4 '14: 98.9M Q1 '15: 81.1M Q2 '15: 82.8M Q3 '15: 101.7M Q4 '15: 105.2M Q1 '16: 126.3M Q2 '16: 120.1M Q3 '16: 112.3M Q4 '16: 111.5M Q1 '17: 101.4M Q2 '17: 113.3M Q3 '17: 118.7M Q4 '17: 137M Q1 '18: 125.5M Q2 '18: 144.7M Q3 '18: 123.9M Q4 '18: 123.8M Q1 '19: 141.4M Q2 '19: 125.4M Q3 '19: 166.8M Q4 '19: 152.1M Q1 '20: 138.1M Q2 '20: 115.6M Q3 '20: 111.4M Q4 '20: 126.7M Q1 '21: 152M Q2 '21: 169.5M Q3 '21: 168.2M Q4 '21: 160.4M Q1 '22: 149.3M Q2 '22: 155.8M Q3 '22: 144.2M Q4 '22: 121.2M Q1 '23: 121.3M Q2 '23: 96.7M Q3 '23: 88.4M Q4 '23: 103.9M Q1 '24: 97M Q2 '24: 92M Q3 '24: 85.1M Q4 '24: 70.6M Q1 '25: 75.5M Q2 '25: 73.9M Q3 '25: 81.2M Q4 '25: 61M Q1 '26: 58.8M Q2 '26: 63M Q3 '26: 31.5M Q4 '26: 22.3M Q1 '27: 16.6M Q2 '27: 27.7M Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25 Q2 '27

Free Cash Flow TTM

0 60M 120M 180M Q2 '12: 65.9M Q3 '12: 64.3M Q4 '12: 59.5M Q1 '13: 63M Q2 '13: 74.4M Q3 '13: 71.4M Q4 '13: 84.4M Q1 '14: 83.4M Q2 '14: 88.2M Q3 '14: 85.8M Q4 '14: 90.8M Q1 '15: 72.9M Q2 '15: 67.7M Q3 '15: 86.7M Q4 '15: 84.8M Q1 '16: 101M Q2 '16: 100M Q3 '16: 88.7M Q4 '16: 87.7M Q1 '17: 74.5M Q2 '17: 85.7M Q3 '17: 85.4M Q4 '17: 104.3M Q1 '18: 98.4M Q2 '18: 118.7M Q3 '18: 108.1M Q4 '18: 110.6M Q1 '19: 128.6M Q2 '19: 112.5M Q3 '19: 153.9M Q4 '19: 140.7M Q1 '20: 127.1M Q2 '20: 103.7M Q3 '20: 97.5M Q4 '20: 110.2M Q1 '21: 130.7M Q2 '21: 149.2M Q3 '21: 149.4M Q4 '21: 145.3M Q1 '22: 139.8M Q2 '22: 148.4M Q3 '22: 133.1M Q4 '22: 108.5M Q1 '23: 108.3M Q2 '23: 83.6M Q3 '23: 78.1M Q4 '23: 93.5M Q1 '24: 86.3M Q2 '24: 79.4M Q3 '24: 74.6M Q4 '24: 56.1M Q1 '25: 59.9M Q2 '25: 59.3M Q3 '25: 65.6M Q4 '25: 50.9M Q1 '26: 49.1M Q2 '26: 51M Q3 '26: 18.7M Q4 '26: 8.5M Q1 '27: 3M Q2 '27: 15.9M Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25 Q2 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q2 '11: 15.7M Q3 '11: 16.2M Q1 '12: 16.2M Q2 '12: 15.8M Q3 '12: 15.2M Q1 '13: 15.3M Q2 '13: 15.1M Q3 '13: 14.9M Q1 '14: 13.9M Q2 '14: 14.1M Q3 '14: 14.4M Q1 '15: 14.4M Q2 '15: 14.2M Q3 '15: 13.3M Q1 '16: 13.1M Q2 '16: 13.2M Q3 '16: 13.3M Q1 '17: 25.2M Q2 '17: 24.9M Q3 '17: 25.1M Q1 '18: 25M Q2 '18: 25M Q3 '18: 24.6M Q1 '19: 24.3M Q2 '19: 24.8M Q3 '19: 25M Q1 '20: 23.9M Q2 '20: 23.4M Q3 '20: 22.2M Q1 '21: 21.6M Q2 '21: 21.1M Q3 '21: 21.2M Q1 '22: 21.1M Q2 '22: 20.4M Q2 '22: 20.4M Q3 '22: 20.2M Q1 '23: 19.5M Q2 '23: 19.2M Q3 '23: 19.3M Q1 '24: 19.3M Q2 '24: 19.4M Q3 '24: 19.4M Q1 '25: 19.3M Q2 '25: 19.2M Q3 '25: 19.1M Q1 '26: 19.1M Q2 '26: 18.5M Q3 '26: 18.3M Q1 '27: 18.4M Q2 '27: 18.5M Q2 '11 Q3 '13 Q1 '16 Q2 '18 Q3 '20 Q3 '22 Q1 '25 Q2 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.50 0.00 2.50 5.00 7.50 Q4 '11: 2.86 Q1 '12: 2.93 Q2 '12: 3.12 Q3 '12: 3.14 Q4 '12: 3.26 Q1 '13: 3.46 Q2 '13: 3.69 Q3 '13: 4.06 Q4 '13: 4.46 Q1 '14: 4.84 Q2 '14: 5.45 Q3 '14: 5.43 Q4 '14: 5.57 Q1 '15: 5.44 Q2 '15: 5.08 Q3 '15: 5.39 Q4 '15: 5.63 Q1 '16: 5.98 Q2 '16: 6.54 Q3 '16: 6.99 Q4 '16: 6.26 Q1 '17: 5.65 Q2 '17: 4.76 Q3 '17: 4.04 Q4 '17: 3.99 Q1 '18: 3.96 Q2 '18: 3.86 Q3 '18: 3.63 Q4 '18: 2.52 Q1 '19: 2.85 Q2 '19: 3.28 Q3 '19: 3.55 Q4 '19: 5.11 Q1 '20: 4.93 Q2 '20: 4.48 Q3 '20: 4.33 Q4 '20: 4.42 Q1 '21: 4.64 Q2 '21: 5.05 Q3 '21: 5.40 Q4 '21: 5.85 Q1 '22: 6.07 Q1 '23: 5.43 Q2 '23: 4.56 Q3 '23: 3.98 Q4 '23: 3.59 Q1 '24: 3.39 Q2 '24: 3.28 Q3 '24: 3.09 Q4 '24: 3.30 Q1 '25: 3.21 Q2 '25: 2.86 Q3 '25: 2.83 Q4 '25: 2.19 Q1 '26: 1.82 Q2 '26: 1.80 Q3 '26: 0.88 Q4 '26: 0.58 Q1 '27: 0.50 Q2 '27: -1.18 Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q2 '23 Q2 '25 Q2 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.